Are THC Gummies Evenly Dosed? What 10 MG Means

Ten gummies.

One hundred milligrams of THC in the package.

Ten milligrams per gummy.

The arithmetic is flawless.

The arithmetic is also the easiest part.

That neat little “10 MG” on the label assumes the cannabinoid was measured correctly, blended throughout the batch, divided consistently between pieces, and confirmed with a test that was designed to catch meaningful variation.

If any one of those steps breaks, the package can still contain 100 milligrams in total without every gummy containing 10.

The dosage number does not tell you everything. It tells you what the product is supposed to deliver. The manufacturing and testing tell you how much confidence that number deserves.

There Are Three Claims Hiding Inside “10 MG”

People tend to use potency, accuracy, and consistency as though they all mean the same thing.

They do not.

Label accuracy asks whether the measured cannabinoid content agrees with the amount printed on the package.

Homogeneity asks whether that cannabinoid is distributed evenly enough across the product or across separate servings.

Batch consistency asks whether the manufacturer can repeat the result when the next production run is made.

A product can perform well on one question and poorly on another.

A package may test close to its total label claim while individual pieces vary. One batch may test beautifully while the next drifts. A formula may be mixed evenly but deposited into pieces with inconsistent weights. Quality is the entire system, not the most flattering number inside it.

An Average Can Tell the Truth and Still Hide the Problem

Imagine a ten-count package labeled at 10 milligrams per gummy.

Now imagine five gummies contain 6 milligrams each and the other five contain 14 milligrams each.

The package still adds up to 100 milligrams.

The average is still 10.

The label can look correct at the package level while the consumer experiences two substantially different servings.

That example is intentionally simple, but it exposes the real question. Was one composite sample tested, or were multiple finished pieces tested separately and compared?

Those procedures do not produce the same evidence.

The Famous Edibles Study Did Not Test Every Piece

One study appears in almost every conversation about inaccurate cannabis edibles.

In 2015, researchers purchased 75 edible medical cannabis products representing 47 brands in San Francisco, Los Angeles, and Seattle. They considered a product accurately labeled when the measured THC and CBD content fell within 10 percent of the label. Only 17 percent met that definition for THC. Twenty-three percent contained more THC than the label stated, while 60 percent contained less.

That result matters. It is also routinely asked to prove more than the study actually tested.

For the analysis, the researchers homogenized the entire contents of each package by crushing or mixing it. They then tested samples from that combined material and adjusted the results for the total product weight.

That design answers a package-level question:

Did the product contain approximately the total cannabinoid amount stated on its label?

It does not tell us how closely each original piece matched the others before the package was ground together.

It was also a limited snapshot of products purchased in three cities more than a decade ago, not a current scorecard for every regulated cannabis or hemp product on the market.

The honest conclusion is not “83 percent of today's gummies are wrong.” The honest conclusion is that label accuracy has been a demonstrated problem, and package-level accuracy still does not answer the separate question of piece-to-piece uniformity.

What Homogeneity Testing Is Actually Trying to Catch

Homogeneity is the quality-control word for even distribution.

For a multi-serving gummy package, a useful homogeneity test does not merely ask whether the entire bag adds up. It examines multiple servings from the lot and compares their cannabinoid concentrations.

New York's regulated adult-use cannabis framework provides a clear example. Its current testing limits call for five samples across a product batch or lot to be tested for potency. For products subject to homogeneity testing, the total THC and CBD in each submitted single-dose sample generally must fall within 25 percent of the mean concentration for that lot, with a separate rule for concentrations below 2 milligrams per dose. The state also requires homogeneity to be established across three consecutive batches or lots.

That is a marijuana-market rule in one state, not a universal hemp requirement and not a claim that 25 percent is the only defensible specification. Its value here is conceptual: the regulator distinguishes a batch average from variation among individual samples, and it distinguishes one passing lot from a repeatable process.

The same questions should matter even where the law asks less of the manufacturer.

The Formula Has to Survive the Factory

On paper, the process sounds easy.

Measure the cannabinoids. Add them to the gummy mixture. Stir. Deposit equal pieces. Package them.

In production, every verb in that sentence needs a control.

• Measure: Was the incoming cannabinoid ingredient identified and assayed before the batch calculation was made?
• Add: Was the correct amount documented against the actual batch size?
• Mix: Was the blend time, temperature, and sequence controlled well enough to distribute the ingredient throughout the matrix?
• Deposit: Were individual piece weights monitored so that equal concentrations were divided into equal servings?
• Confirm: Were multiple finished units sampled in a way that could reveal variation instead of averaging it away?

A good formula is only the beginning. The batch record shows whether that formula was followed. In-process checks show whether the equipment stayed under control. Finished-product testing shows what came out the other end.

If the only evidence is a single potency number from a sample whose location and preparation are unclear, there are still important questions unanswered.

A COA Is Evidence. Read What It Is Evidence Of.

A certificate of analysis can confirm a great deal about the material that reached the laboratory.

It can identify the sample and lot, report measured cannabinoids, document a test date, name the laboratory, list the method, and show results for contaminants included in the requested panel.

What it proves about every gummy depends on how the sample was selected and prepared.

If ten gummies were blended into one composite before analysis, the result may be useful for estimating their combined or average potency. It cannot show the original result for each of those ten pieces because that information was physically combined.

If multiple finished gummies were analyzed separately, the data can say considerably more about piece-to-piece variation.

This is not an argument against COAs. It is an argument for reading the sample description, the units, the lot number, and the test design before deciding exactly what the report proves. We will take apart that problem in detail later this week.

Can You Split a Gummy in Half?

You can physically cut almost any gummy in half.

That does not automatically mean each half contains exactly half the labeled cannabinoid amount.

If the product is genuinely homogeneous throughout each piece and you divide it evenly by weight, half is a reasonable estimate. If the active ingredients are unevenly distributed inside the gummy, a visually perfect cut cannot fix the underlying variation.

That is why the labeled serving matters. A product designed and tested as one whole gummy per serving offers a clearer unit than a brand casually telling customers to cut an unscored piece into whatever fraction produces the desired arithmetic.

For anyone new to cannabinoid products, the broader rule remains simple: start conservatively, follow the actual product label, allow sufficient time before taking more, and do not assume two different brands' “10 MG” products are interchangeable. Our beginner's guide to hemp products gives a wider map of product types and potency tiers.

What Should a Brand Be Able to Show?

Most customers will never review a master manufacturing record. They should not need to become auditors just to buy a gummy.

The brand, however, should have enough documentation to answer basic quality questions without improvising.

• Which lot is this package from?
• Was the finished product tested, not only the raw cannabinoid ingredient?
• Does the reported potency refer to one serving, one gram, or the entire package?
• Were multiple finished units evaluated for homogeneity?
• What acceptance range did the manufacturer use?
• Can the process reproduce the result across more than one batch?

A glossy package cannot answer those questions.

“Lab tested” cannot answer them by itself either.

The phrase tells you that a test happened. Quality begins when somebody can tell you what was tested, how it was sampled, which batch it represents, and what the result was supposed to demonstrate.

The Same Dose Can Still Feel Different

There is one more distinction worth protecting.

A chemically consistent gummy does not guarantee an identical subjective experience every time.

Food, metabolism, tolerance, medications, alcohol, and timing can all change how an edible is experienced. The CDC notes that edible cannabis products may take 30 minutes to two hours to produce intoxicating effects and that duration and intensity can vary with the amount consumed, whether it was eaten on an empty stomach, and other factors.

That does not make manufacturing consistency optional.

It makes consistency the part the manufacturer can control.

Your biology already supplies enough variables. The gummy should not add avoidable ones.

Read Past the Milligrams

The milligram number matters.

It tells you the intended dose. It helps you compare products. It gives you a starting point for responsible use.

It just cannot grade its own credibility.

For that, look for the lot. Look for the finished-product COA. Check whether the reported units match the label. Ask whether multiple units were tested. Pay attention to whether the brand treats one passing number like the end of quality control or the beginning of it.

Ten milligrams should mean more than “we divided the batch total by the number of molds.” It should mean the company did the work required to make one gummy behave like one defined serving.

New to hemp? Find your starting tier.

---

FAQ

Are THC gummies evenly dosed?

They should be, but the label alone cannot prove it. Even dosing depends on controlled formulation, mixing, depositing, and finished-product testing. The strongest evidence comes from testing multiple finished servings separately and comparing the results, rather than relying only on one composite or batch-average potency number.

What does homogeneity mean for gummies?

Homogeneity means the cannabinoids are distributed consistently throughout the product or among its servings. A homogeneity test evaluates variation across multiple samples. It answers a different question from total-package potency.

Can a package test at 100 mg while individual gummies vary?

Yes. A correct total or average does not mathematically require every piece to be identical. Multiple pieces with different amounts can still add up to the correct package total. Separate-unit testing is needed to characterize piece-to-piece variation.

Does a COA prove every gummy has the labeled dose?

Not automatically. A COA reports results for the sample submitted to the laboratory. What it proves about every gummy depends on how the lot was sampled, whether units were tested separately or combined, how the sample was prepared, and which acceptance criteria were applied.

Is half of a 10 mg gummy exactly 5 mg?

It is an estimate, not an automatic guarantee. If the cannabinoid is homogeneous throughout the gummy and the piece is divided evenly by weight, half should approximate half the dose. If the product is not uniform, cutting it evenly cannot correct the distribution problem. Follow the labeled serving size and product directions.

---

Sources & Further Reading

Vandrey R, et al. Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products. JAMA. 2015. A study of 75 edible products from 47 brands that measured package-level label accuracy after homogenizing each product's contents.

New York State Office of Cannabis Management. Cannabis Testing Limits. Revised February 9, 2026. Current potency and homogeneity sampling limits for New York's regulated adult-use cannabis market.

Centers for Disease Control and Prevention. Cannabis and Poisoning. Consumer guidance on delayed onset, duration, and unpredictability of edible cannabis products.

---

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. For adults 21+ only. Individual experiences vary. Always review product labeling and verify applicable state and local laws before ordering or using hemp-derived products.